CR7877A - Derivados de 4-tetrazolil-4-fenilpiperidina para tratar el dolor - Google Patents

Derivados de 4-tetrazolil-4-fenilpiperidina para tratar el dolor

Info

Publication number
CR7877A
CR7877A CR7877A CR7877A CR7877A CR 7877 A CR7877 A CR 7877A CR 7877 A CR7877 A CR 7877A CR 7877 A CR7877 A CR 7877A CR 7877 A CR7877 A CR 7877A
Authority
CR
Costa Rica
Prior art keywords
phenylpiperidine
tetrazolil
derivatives
treat pain
tetrazolyl
Prior art date
Application number
CR7877A
Other languages
English (en)
Inventor
Chen Zhengming
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of CR7877A publication Critical patent/CR7877A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D211/60—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D211/62—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4
    • C07D211/64—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals attached in position 4 having an aryl radical as the second substituent in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Otolaryngology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Se presentan compuestos de 4-Tetrazolil-4-fenilpiperidina, composiciones que comprenden una cantidad efectiva del compuesto de 4-Tetrazolil-4-fenilpiperidina, metodos para tratar o prevenir dolor o diarrea en un animal, que comprenden administrarle a un animal que lo necesita una cantidad efectiva de un compuesto de 4-Tetrazolil-4-fenilpiperidina.
CR7877A 2002-11-18 2005-06-16 Derivados de 4-tetrazolil-4-fenilpiperidina para tratar el dolor CR7877A (es)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US42738102P 2002-11-18 2002-11-18
US46027803P 2003-04-03 2003-04-03
US48848803P 2003-07-17 2003-07-17
US10/714,066 US7202259B2 (en) 2002-11-18 2003-11-13 Therapeutic agents useful for treating pain

Publications (1)

Publication Number Publication Date
CR7877A true CR7877A (es) 2005-11-30

Family

ID=32777221

Family Applications (2)

Application Number Title Priority Date Filing Date
CR7877A CR7877A (es) 2002-11-18 2005-06-16 Derivados de 4-tetrazolil-4-fenilpiperidina para tratar el dolor
CR11037A CR11037A (es) 2002-11-18 2009-09-21 Derivados de 4-tetrazolil -4fenilpiperidina para tratar el dolor (divisional)

Family Applications After (1)

Application Number Title Priority Date Filing Date
CR11037A CR11037A (es) 2002-11-18 2009-09-21 Derivados de 4-tetrazolil -4fenilpiperidina para tratar el dolor (divisional)

Country Status (37)

Country Link
US (3) US7202259B2 (es)
EP (2) EP1803718B1 (es)
JP (2) JP4601429B2 (es)
KR (1) KR20050115221A (es)
CN (2) CN100567288C (es)
AP (1) AP2210A (es)
AR (1) AR047008A1 (es)
AT (2) ATE402167T1 (es)
AU (2) AU2003294313B2 (es)
BR (1) BR0316305A (es)
CA (1) CA2506242C (es)
CO (1) CO5690588A2 (es)
CR (2) CR7877A (es)
CY (2) CY1107682T1 (es)
DE (2) DE60322451D1 (es)
DK (2) DK1562932T3 (es)
EA (1) EA008621B1 (es)
EC (1) ECSP055840A (es)
ES (2) ES2312150T3 (es)
GE (1) GEP20084539B (es)
HK (1) HK1086829A1 (es)
IL (1) IL209352A0 (es)
IS (2) IS2720B (es)
MA (1) MA27565A1 (es)
ME (1) MEP48108A (es)
MX (1) MXPA05004669A (es)
MY (1) MY135647A (es)
NI (1) NI200500087A (es)
NO (1) NO20052894D0 (es)
NZ (2) NZ572685A (es)
OA (1) OA13010A (es)
PT (2) PT1562932E (es)
RS (1) RS51047B (es)
SG (1) SG165998A1 (es)
SI (2) SI1803718T1 (es)
TW (2) TW200819436A (es)
WO (1) WO2004046132A1 (es)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
US8790689B2 (en) * 2003-04-30 2014-07-29 Purdue Pharma L.P. Tamper resistant transdermal dosage form
ME00276B (me) 2003-04-30 2011-05-10 Purdue Pharma Lp Transdermalni dozni oblik otporan na promjene koje sadrže komponentu aktivnog sredstva i komponentu suprotnog sredstva na mjestu koji je ispod sloja aktivnog sredstva
BRPI0506548A (pt) * 2004-01-30 2007-05-02 Euro Celtique Sa métodos para produzir compostos de 4-tetrazolil-4-fenilpiperidina
SE0401656D0 (sv) * 2004-06-24 2004-06-24 Astrazeneca Ab Chemical compounds
BRPI0619679A2 (pt) * 2005-11-21 2011-10-11 Purdue Pharma Lp compostos 4-oxadiazolil-piperidina e seus usos
US20080051380A1 (en) 2006-08-25 2008-02-28 Auerbach Alan H Methods and compositions for treating cancer
US8771693B2 (en) 2009-10-27 2014-07-08 Beth Israel Deaconess Medical Center, Inc. Methods and compositions for the generation and use of conformation-specific antibodies
WO2012038813A1 (en) 2010-09-21 2012-03-29 Purdue Pharma L.P. Buprenorphine analogs
CN102648915B (zh) * 2011-02-28 2015-04-15 鲁南制药集团股份有限公司 一种治疗或预防神经病理性疼痛的药物组合物
US10487114B2 (en) 2011-04-27 2019-11-26 Beth Israel Deaconess Medical Center, Inc. Methods for administering peptides for the generation of effective c/s conformation-specific antibodies to a human subject in need thereof
US10138207B2 (en) 2012-11-09 2018-11-27 Purdue Pharma, L.P. Benzomorphan analogs and the use thereof
JP6317755B2 (ja) 2012-12-07 2018-04-25 パーデュー、ファーマ、リミテッド、パートナーシップ オピオイド受容体モジュレーターとしてのブプレノルフィン類似体
ES2631197T3 (es) 2012-12-14 2017-08-29 Purdue Pharma Lp Análogos de piridonamorfinano y actividad biológica sobre los receptores opiodes
US8987287B2 (en) 2012-12-14 2015-03-24 Purdue Pharma L.P. Spirocyclic morphinans and their use
US9056836B2 (en) 2013-01-31 2015-06-16 Purdue Pharma L.P. Benzomorphan analogs and the use thereof
US8969358B2 (en) 2013-03-15 2015-03-03 Purdue Pharma L.P. Buprenorphine analogs
EP3087073B1 (en) 2013-12-26 2018-07-04 Purdue Pharma LP 10-substituted morphinan hydantoins
WO2015097546A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Propellane-based compounds and their use as opioid receptor modulators
CA2934913A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Ring-contracted morphinans and the use thereof
WO2015097545A1 (en) 2013-12-26 2015-07-02 Purdue Pharma L.P. Opioid receptor modulating oxabicyclo[2.2.2]octane morphinans
US9988392B2 (en) 2013-12-26 2018-06-05 Purdue Pharma L.P. 7-beta-alkyl analogs of orvinols
EP3086790A4 (en) 2013-12-27 2017-07-19 Purdue Pharma LP 6-substituted and 7-substituted morphinan analogs and the use thereof
JP2017521373A (ja) 2014-05-27 2017-08-03 パーデュー、ファーマ、リミテッド、パートナーシップ スピロ環モルフィナン及びその使用
MA40171A (fr) 2014-06-13 2017-04-19 Purdue Pharma Lp Dérivés d'azamophinan et leur utilisation
MA41125A (fr) 2014-12-05 2017-10-10 Purdue Pharma Lp Dérivés de 6.7-cyclomorphinane et leur utilisation
CA3018750A1 (en) 2016-03-22 2017-09-28 Regents Of The University Of Minnesota Combination for treating pain
US20180028521A1 (en) 2016-07-29 2018-02-01 Janssen Pharmaceutica Nv Methods of Treating Prostate Cancer
WO2018125716A1 (en) 2017-01-02 2018-07-05 Purdue Pharma L.P. Morphinan derivatives and use thereof
BR112023023702A2 (pt) * 2021-05-21 2024-01-30 Purdue Pharma Lp Métodos de tratamento da cistite intersticial/síndrome da dor na bexiga
WO2023250190A1 (en) * 2022-06-24 2023-12-28 Purdue Pharma L.P. Methods of treating or preventing overactive bladder syndrome

Family Cites Families (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3536809A (en) * 1969-02-17 1970-10-27 Alza Corp Medication method
US3598122A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
US3598123A (en) * 1969-04-01 1971-08-10 Alza Corp Bandage for administering drugs
BE775611A (fr) 1970-11-24 1972-03-16 Synthelabo Derives de la (diphenyl-3,3 propyl-1)-1 piperidine, leur preparation etles medicaments qui en contiennent
US4076717A (en) * 1971-12-15 1978-02-28 G. D. Searle & Co. Derivatives of 1-(3-cyano-3,3-diphenylpropyl)-4-phenylpiperidine-4-carboxylic acid
US3845770A (en) * 1972-06-05 1974-11-05 Alza Corp Osmatic dispensing device for releasing beneficial agent
US3916899A (en) * 1973-04-25 1975-11-04 Alza Corp Osmotic dispensing device with maximum and minimum sizes for the passageway
US4008719A (en) * 1976-02-02 1977-02-22 Alza Corporation Osmotic system having laminar arrangement for programming delivery of active agent
IE58110B1 (en) * 1984-10-30 1993-07-14 Elan Corp Plc Controlled release powder and process for its preparation
DK162087D0 (da) * 1987-03-31 1987-03-31 Ferrosan As Piperidinforbindelser, deres fremstilling og anvendelse
US4831192A (en) * 1987-12-31 1989-05-16 Boc, Inc. Methods of preparing 4-heteropentacyclic-4-(N-phenyl)amido) piperidine derivatives and intermediate compounds
US5073543A (en) * 1988-07-21 1991-12-17 G. D. Searle & Co. Controlled release formulations of trophic factors in ganglioside-lipsome vehicle
IT1229203B (it) * 1989-03-22 1991-07-25 Bioresearch Spa Impiego di acido 5 metiltetraidrofolico, di acido 5 formiltetraidrofolico e dei loro sali farmaceuticamente accettabili per la preparazione di composizioni farmaceutiche in forma a rilascio controllato attive nella terapia dei disturbi mentali organici e composizioni farmaceutiche relative.
US5120548A (en) * 1989-11-07 1992-06-09 Merck & Co., Inc. Swelling modulated polymeric drug delivery device
US5733566A (en) * 1990-05-15 1998-03-31 Alkermes Controlled Therapeutics Inc. Ii Controlled release of antiparasitic agents in animals
US5698155A (en) * 1991-05-31 1997-12-16 Gs Technologies, Inc. Method for the manufacture of pharmaceutical cellulose capsules
US5580578A (en) * 1992-01-27 1996-12-03 Euro-Celtique, S.A. Controlled release formulations coated with aqueous dispersions of acrylic polymers
US5449989A (en) 1992-07-31 1995-09-12 Correa; Paulo N. Energy conversion system
US5606037A (en) 1992-11-09 1997-02-25 Biochem Pharma Inc. Processes antineoplastic heteronaphthoquinones
US5736523A (en) 1992-11-09 1998-04-07 Biochem Pharma Inc. Antineoplastic heteronapthoquinones
US5591767A (en) * 1993-01-25 1997-01-07 Pharmetrix Corporation Liquid reservoir transdermal patch for the administration of ketorolac
IT1270594B (it) * 1994-07-07 1997-05-07 Recordati Chem Pharm Composizione farmaceutica a rilascio controllato di moguisteina in sospensione liquida
US5849737A (en) 1995-04-14 1998-12-15 The Regents Of The University Of California Compositions and methods for treating pain
US6166085A (en) 1995-04-14 2000-12-26 The Regents Of The University Of California Method of producing analgesia
US6136839A (en) * 1995-06-12 2000-10-24 G. D. Searle & Co. Treatment of inflammation and inflammation-related disorders with a combination of a cyclooxygenase-2 inhibitor and a 5-lipoxygenase inhibitor
US5849761A (en) 1995-09-12 1998-12-15 Regents Of The University Of California Peripherally active anti-hyperalgesic opiates
US6573282B1 (en) 1995-09-12 2003-06-03 Adolor Corporation Peripherally active anti-hyperalgesic opiates
WO1997024325A1 (en) 1995-12-28 1997-07-10 Takeda Chemical Industries, Ltd. DIPHENYLMETHANE DERIVATIVES AS MIP-1α/RANTES RECEPTOR ANTAGONISTS
US6221888B1 (en) 1997-05-29 2001-04-24 Merck & Co., Inc. Sulfonamides as cell adhesion inhibitors
CA2293247C (en) * 1997-06-10 2005-04-12 Synthon B.V. 4-phenylpiperidine compounds
CA2322136A1 (en) 1998-03-06 1999-09-10 Ludo Edmond Josephine Kennis Glycine transport inhibitors
US6423519B1 (en) * 1998-07-15 2002-07-23 Gpc Biotech Inc. Compositions and methods for inhibiting fungal growth
US7217714B1 (en) 1998-12-23 2007-05-15 Agouron Pharmaceuticals, Inc. CCR5 modulators
PE20001420A1 (es) 1998-12-23 2000-12-18 Pfizer Moduladores de ccr5
DE60014603T2 (de) 1999-03-12 2006-02-16 Boehringer Ingelheim Pharmaceuticals, Inc., Ridgefield Heterocyklischer harnstoff und verwandte verbindungen als entzündungshemmende mittel
EP1219294A4 (en) 1999-09-20 2005-01-26 ANTAGONISTS OF THE MELANIN CONCENTRATING HORMON
CA2324330A1 (en) 1999-11-08 2001-05-08 Ssp Co., Ltd. 4-hydroxy-4-phenylpiperidine derivatives and pharmaceuticals containing the same
JP2003524634A (ja) 1999-12-06 2003-08-19 ユーロ−セルティーク，エス．エイ． ノシセプチン受容体親和性を有するベンズイミダゾール化合物
US6486142B2 (en) 1999-12-22 2002-11-26 Merck Frosst Canada & Co. Phosphonic acid derivatives as inhibitors of protein tyrosine phosphatase 1B (PTP-1B)
US6608052B2 (en) 2000-02-16 2003-08-19 Boehringer Ingelheim Pharmaceuticals, Inc. Compounds useful as anti-inflammatory agents
US6703525B2 (en) 2000-02-16 2004-03-09 Boehringer Ingelheim Pharmaceuticals, Inc. Sulfonamide intermediates and methods of producing same
US6790854B2 (en) 2000-03-24 2004-09-14 Meiji Seika Kaisha, Ltd. Diphenylalkylamine derivatives useful as opioid receptor agonists
US6544981B2 (en) 2000-06-09 2003-04-08 Bristol-Myers Squibb Company Lactam inhibitors of factor Xa and method
TW579375B (en) 2000-10-12 2004-03-11 Ssp Co Ltd 2,2-Diphenylbutanamide derivatives and medicines containing the same
WO2002038185A2 (en) 2000-11-13 2002-05-16 Atrix Laboratories, Inc. Injectable sustained release delivery system with loperamide
US7202259B2 (en) * 2002-11-18 2007-04-10 Euro-Celtique S.A. Therapeutic agents useful for treating pain
BRPI0506548A (pt) * 2004-01-30 2007-05-02 Euro Celtique Sa métodos para produzir compostos de 4-tetrazolil-4-fenilpiperidina

Also Published As

Publication number Publication date
CA2506242A1 (en) 2004-06-03
TW200418828A (en) 2004-10-01
CY1107682T1 (el) 2013-04-18
EP1803718A1 (en) 2007-07-04
ECSP055840A (es) 2005-08-11
EA200500726A1 (ru) 2005-10-27
KR20050115221A (ko) 2005-12-07
DK1803718T3 (da) 2008-10-27
JP2010163452A (ja) 2010-07-29
NO20052894L (no) 2005-06-14
CR11037A (es) 2009-10-29
ES2312150T3 (es) 2009-02-16
ATE402167T1 (de) 2008-08-15
CN101648941A (zh) 2010-02-17
NZ540068A (en) 2007-07-27
AU2010246411A1 (en) 2010-12-16
JP4601429B2 (ja) 2010-12-22
HK1086829A1 (en) 2006-09-29
US20100069437A1 (en) 2010-03-18
PT1803718E (pt) 2008-09-26
TW200819436A (en) 2008-05-01
IS2720B (is) 2011-02-15
CN1711256A (zh) 2005-12-21
ATE358674T1 (de) 2007-04-15
MEP48108A (en) 2011-02-10
US7687518B2 (en) 2010-03-30
ES2285235T3 (es) 2007-11-16
AR047008A1 (es) 2006-01-04
EP1562932B1 (en) 2007-04-04
EP1562932B9 (en) 2007-09-12
US20070179141A1 (en) 2007-08-02
AU2003294313A1 (en) 2004-06-15
OA13010A (en) 2006-11-10
BR0316305A (pt) 2005-09-27
RS20050375A (en) 2007-11-15
US8026254B2 (en) 2011-09-27
DK1562932T3 (da) 2007-08-13
PT1562932E (pt) 2007-07-02
AP2210A (en) 2011-02-25
IL209352A0 (en) 2011-01-31
SI1803718T1 (sl) 2008-12-31
EP1803718B1 (en) 2008-07-23
IS8913A (is) 2010-07-21
DE60313021D1 (de) 2007-05-16
RS51047B (sr) 2010-10-31
CN100567288C (zh) 2009-12-09
DE60322451D1 (de) 2008-09-04
US20040152689A1 (en) 2004-08-05
NZ572685A (en) 2010-06-25
SG165998A1 (en) 2010-11-29
CY1108422T1 (el) 2014-04-09
JP2006525944A (ja) 2006-11-16
CO5690588A2 (es) 2006-10-31
DE60313021T2 (de) 2007-12-13
EA008621B1 (ru) 2007-06-29
AP2005003297A0 (en) 2005-06-30
SI1562932T1 (sl) 2007-08-31
CA2506242C (en) 2011-07-05
EP1562932A1 (en) 2005-08-17
AU2003294313B2 (en) 2010-08-26
GEP20084539B (en) 2008-11-25
NO20052894D0 (no) 2005-06-14
MY135647A (en) 2008-06-30
US7202259B2 (en) 2007-04-10
MXPA05004669A (es) 2005-06-08
WO2004046132A1 (en) 2004-06-03
MA27565A1 (fr) 2005-10-03
TWI343917B (en) 2011-06-21
IS7812A (is) 2005-04-19
NI200500087A (es) 2007-07-24

Similar Documents

Publication Publication Date Title
CR7877A (es) Derivados de 4-tetrazolil-4-fenilpiperidina para tratar el dolor
GT200600160A (es) Tratamiento del dolor
ECSP034642A (es) Derivados de tetralona como agentes antitumorales
BRPI0413848A (pt) composto, processo para preparar o composto, composição terapêutica para prevenir inflamação e apoptose, método para prevenir inflamação e apoptose, e, uso de composto inibidor de caspase, ou de seu sal, ou de seu estereoisÈmero
PE20020521A1 (es) Compuestos heterociclicos sustituidos para tratar la resistencia a multiples drogas
CR8507A (es) Derivados de 2- piridiniletilbenzamida
PH12013500913A1 (en) Substituted-quinoxaline-type-piperidine compounds and the uses thereof
ECSP055582A (es) Derivados de benzotiazol que tienen actividad agonista de beta-2-adrenorreceptor
AR060089A1 (es) Tratamiento del dolor
BR0309343A (pt) Composto, composição farmacêutica, uso de um composto, e, método de tratamento ou profilaxia de doenças ou condições humanas
DK1664016T3 (da) Terapeutiske midler, der er anvendelige til behandling af smerter
WO2005030766A8 (en) Phenyl - carboxamide compounds useful for treating pain
MXPA05000765A (es) Compuestos de 5-ariltetrazola, composiciones de los mismos y usos para los mismos.
ECSP066685A (es) Composición que comprende un extracto acuoso de hojas de vid roja y un agente que mejora la circulación sanguínea para el tratamiento de insuficiencias venosas crónicas
PE20020909A1 (es) Una combinacion que comprende combretastatina y agentes anticancerigenos
UY28076A1 (es) Procedimiento para aumentar el rendimiento de las leguminosas.
HN2003000063A (es) Derivados de nicotinamida y una sal de tiotropio en combinacion para el tratamiento de enfermedades.
PA8597501A1 (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol
EA200601249A1 (ru) Пиперазины, пригодные для лечения боли
EA200800788A1 (ru) Фунгицидные смеси на основе триазолов
AR050722A1 (es) Combinacion antiparasitaria de compuestos activos
NI200700218A (es) Derivados de amida como ligandos de canales iónicos y composiciones farmacéuticas y métodos para usar los mismos.
ES2171838T3 (es) Uso de 3-(4-hexiloxi-1,2,5-tiadiazol-3-il)-1,2,5,6-tetrahidro-1-metilpiridina (xanomelina) para el tratamiento del trastorno bipolar.
DE602004030545D1 (de) Behandlung proliferativer erkrankungen mit epothilon-derivaten und bestrahlung
ECSP066429A (es) Mezclas fungicidas